he quickly notes they were more than an art group; they created a movement, one with remarkable influence on Chicano art history. “That movement continues today, and it’s very expansive,” he ...

EVP of Merck Group, and president of Merck China, told China Daily Website during an exclusive interview at the Boao Forum for Asia in South China's Hainan province, on March 26. "These are all ...

How a 1970s Chicano art group defied the mainstream and made history “That movement continues today, and it’s very expansive,” he says. “There’s a lot of books, films and things that ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. “ASCO: Without Permission” is an upcoming ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

As Goldberg explained, he had been added—for reasons unknown to him—to a group discussion on the Signal messaging app that appeared to involve some of the highest-ranking figures in the U.S ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite this ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or Pneumococcal 21-valent Conjugate Vaccine, for active ...

The Atlantic has published the texts from a Signal group chat that discussed U.S. military plans for strikes in Yemen after some Trump administration officials denied classified information was ...

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the latest in a series of cross-border deals between Western ...

Merck & Co. is handing over $200 million to China ... Meanwhile, AstraZeneca paid CSPC Pharmaceutical Group $100 million last year for a preclinical Lp(a) disrupter. “Elevated blood ...